Naltrexone Treatment Centers in North Dakota

Adults with a clinical diagnosis of opioid use disorder (OUD) are eligible for naltrexone treatment in North Dakota. A licensed clinician confirms the diagnosis during intake using DSM-5 criteria, and the provider verifies identity and medical history before the first dose or injection.

Costs can vary modestly by location — Fargo has more naltrexone providers competing on price, and several FQHCs offering sliding-scale fees. Rural North Dakota has fewer options, and patients may incur travel costs, but per-visit fees are often comparable.

Yes — North Dakota Medicaid can pay retroactively for up to 3 months of prior treatment in most cases, provided you were eligible during that period. Save all receipts and itemized statements from naltrexone providers and submit them to the Medicaid enrollment caseworker.

Yes. Medicare Part B covers methadone through enrolled Opioid Treatment Programs and Part D covers buprenorphine and naltrexone prescriptions. Medicare Advantage plans in North Dakota include the same MAT benefits under the integrated plan structure.

Yes. DEA rules were permanently expanded in 2024 to allow audio-video telehealth for initial buprenorphine prescribing, and North Dakota law mirrors federal policy. Methadone induction still requires an in-person visit at an OTP for the first dose, though subsequent counseling can be delivered via telehealth. Naltrexone can be prescribed via telehealth with labs done in North Dakota.

Yes. Buprenorphine and naltrexone prescriptions travel with you. For methadone, your clinic coordinates with an out-of-state guest-dosing OTP; plan at least 2 weeks ahead for domestic travel, longer for international. Ask the clinic about guest-dosing letters.

The first appointment typically runs 90–180 minutes: medical history, physical exam, intake paperwork, counseling assessment, lab tests, and the first dose or prescription. Plan for 2–3 hours and arrange transportation in case of post-dose drowsiness.

Expect questions about your substance use history, overdose history, medical and mental-health conditions, current medications, pregnancy risk, social support, housing, legal status, and treatment goals. Answers help tailor the plan — honesty produces better clinical care, and answers are protected under 42 CFR Part 2.

Combining alcohol with methadone or buprenorphine increases sedation and respiratory-depression risk; avoidance is strongly recommended. Naltrexone treats alcohol use disorder directly and is not impaired by occasional drinking, but heavy drinking can still cause liver harm. Be honest about use with your North Dakota clinician.

Yes. Methadone and buprenorphine are the evidence-based standard of care in pregnancy, endorsed by ACOG and SAMHSA. Staying on MAT protects both mother and fetus; unmedicated withdrawal is riskier than continued MAT. North Dakota providers coordinate care with obstetrics.

Common options include cognitive-behavioral therapy, motivational interviewing, contingency management, group counseling, and trauma-focused therapy. Many North Dakota programs also offer peer-recovery support. The clinical team matches you with the modality most aligned to your goals.

Yes. Group members sign confidentiality agreements, and the clinician protects group content under 42 CFR Part 2. Enforcement between group members depends on honor among peers, but legal protections limit disclosure by the clinic or clinician.